Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00120198
Recruitment Status : Terminated (slow accrual)
First Posted : July 15, 2005
Last Update Posted : November 16, 2007
Tibotec Pharmaceutical Limited
Information provided by:
Geriatric Oncology Consortium

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : September 2006